ORIGINAL research AND pre clinical organization

We have a novel strontium based cream which is showing promise in multiple skin models in animals and early stage human testing.
Our TechnologyContact Us
We are an original research and pre-clinical organization that has taken rare earth metals and investigated their tremendous clinical potential in animal models.

About Galleon Bio LLC

Galleon has a novel strontium based cream which is showing promise in multiple skin models in animals and early stage human testing.
‍
Multiple patent holdings and follow-up compounds in development demonstrate our stong desire to become a clinical company in the near term and we are currently assessing partnerships to get our discoveries into key global markets.

Galleon Bio’s veteran leadership has brought many molecules to market with giants like Pfizer to rising stars like Evofem around the world. Partners in AsiaPac, and Latam are invited to get in touch and share in our successes.
Our Team

Our Technology

Galleon Bio has developed a novel topical treatment, CB400, specifically designed to address several unmet needs in the management of psoriasis and other dermatological conditions, including atopic dermatitis. The preclinical and clinical development programs to achieve regulatory approval are currently designed
Learn More

Market Opportunity

Psoriasis represents a global health problem, with a prevalence ranging between 1% and 3% in most countries. More than 100 million people globally suffer from psoriasis, with 9 million of them in the USA and 14 million in Europe. Due to demographic trends new cases of psoriasis are emerging annually at a fast rate.
Learn More

Contact Us Today

We look forward to talking to companies with a shared future in dermatology and neuropathic pain in the first instance.
Contact Us

Contact Details

Galleon Bio LLC.
511 S Orange Ave #2069
Newark NJ 07103
Call Us
+1 (862) 320-9990
Email
info@galleonbio.com
© Copyright Galleon Bio LLC 2020. All Rights Reserved.